Your browser doesn't support javascript.
loading
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Haldar, Pranabashis; Brightling, Christopher E; Singapuri, Amisha; Hargadon, Beverley; Gupta, Sumit; Monteiro, William; Bradding, Peter; Green, Ruth H; Wardlaw, Andrew J; Ortega, Hector; Pavord, Ian D.
Afiliación
  • Haldar P; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Brightling CE; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Singapuri A; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Hargadon B; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Gupta S; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Monteiro W; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Bradding P; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Green RH; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Wardlaw AJ; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Ortega H; Respiratory Therapeutic Area Unit, R&D, GlaxoSmithKline, Research Triangle Park, NC.
  • Pavord ID; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford, United Kingdom. Electronic address: ian.pavord@ndm.ox.ac.uk.
J Allergy Clin Immunol ; 133(3): 921-3, 2014 Mar.
Article en En | MEDLINE | ID: mdl-24418480
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Interleucina-5 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Interleucina-5 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido